已收盘 02-17 16:00:00 美东时间
0.000
0.00%
Castle Biosciences announced that its executive management will present a company overview at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 12:30 p.m. Eastern time. A live audio webcast will be available on the company’s website, with a replay following the event. The company, focused on improving health through innovative diagnostic tests for diseases like skin cancer and uveal melanoma, also highlighted its R&D init...
07-29 11:00
Derek Maetzold, founder, president, and CEO of Castle Biosciences, was named a 2025 Most Admired CEO by the Houston Business Journal. The award recognizes leaders who demonstrate outstanding financial stewardship, foster inclusive workplace cultures, and contribute to the Houston community. Maetzold has led Castle Biosciences to improve patient outcomes through innovative diagnostic tests for skin cancers, Barrett's esophagus, and uveal melanoma....
07-25 11:00
Castellum, Inc. CEO Glen Ives released a letter to shareholders, highlighting the company's progress over the past year. Since assuming the CEO role in July 2024, Castellum has transitioned to Phase 2, focusing on organic growth and strengthening its foundational platform. Key achievements include raising over $16 million, reducing long-term debt to under $5 million, winning a $103.3 million contract, establishing mentor-protégé relationships, an...
07-14 10:45
Dr. David Lim joins Evolent as chief clinical officer John Way joins Evolent as CFO, Performance Suite WASHINGTON, July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company fo...
07-09 20:00
Castellum, Inc., a cybersecurity and software services company, announced the creation of a new wholly owned subsidiary, Castellum Advanced Technology Products, Inc. (CATP), to focus on developing advanced technology products and potential equity investments in tech companies. CEO Glen Ives emphasized that leveraging cutting-edge technology is crucial for modern defense strategies. The move aims to enhance Castellum's ability to deliver better so...
06-24 10:45
Castellum, Inc. (NYSE-American: CTM) announced the closing of a $5.0 million public offering of 4,166,667 Units at $1.20 per Unit. Each Unit includes one share of common stock and one warrant exercisable at $1.22 per share with a 60-day expiration. Proceeds will be used for working capital and corporate purposes. Maxim Group LLC acted as the placement agent. The offering was conducted under a previously filed SEC registration statement.
06-16 10:45
Castellum, Inc. announced the early retirement of its promissory note with the Buckhout Charitable Remainder Trust, 15 months ahead of its maturity date. This reflects significant improvements in the company’s balance sheet, reducing long-term debt from over $12 million to under $5 million. The note was originally issued in November 2019 as part of the acquisition of Corvus Consulting. The move strengthens Castellum’s financial position, allowing...
06-05 10:45
继上周连续两日减持特斯拉套现约1.7亿美元后,木头姐昨日再度出货超8000股;此外,木头姐继续加码Shopify、小牛电动、生物技术公司DNA等 >>
2022-04-26 19:52
SEATTLE, Feb. 17, 2022 /PRNewswire/ -- Vera Whole Health, Inc. ("Vera") announc...
2022-02-17 20:10
NEW ORLEANS, Jan. 7, 2022 /PRNewswire/ -- Former Attorney General of Louisiana ...
2022-01-08 10:36